呼气末二氧化碳在心脏骤停中的预后准确性:系统评价与荟萃分析
该系统评价与荟萃分析纳入14项研究共3186例成人心脏骤停患者,评估不同时间点和界值的呼气末二氧化碳(ETCO2)对自主循环恢复(ROSC)的预测准确性。初始ETCO2最佳界值19.8 mm Hg(敏感度0.75,特异度0.53),10分钟最佳界值15.7 mm Hg(敏感度0.91,特异度0.68),20分钟最佳界值8.5 mm Hg(敏感度0.95,特异度0.78)。AUC在20分钟最高为0.88,10分钟为0.82,初始仅0.67。结论认为初始ETCO2预测准确性有限,10和20分钟以10 mm Hg为界值时阴性预测值超过0.95,但满足终止复苏(TOR)严格标准需更低界值如5 mm Hg或联合其他预后指标,连续ETCO2监测可考虑作为当前TOR指南的潜在辅助,研究间显著异质性需谨慎解读。
要点
- 成人心脏骤停患者初始ETCO2预测ROSC的汇总AUC仅0.67,准确性有限。
- 10分钟ETCO2最佳界值15.7 mm Hg,敏感度0.91(95%CI 0.72-0.97),特异度0.68(95%CI 0.56-0.78)。
- 20分钟ETCO2最佳界值8.5 mm Hg,敏感度0.95(95%CI 0.53-0.99),特异度0.78(95%CI 0.39-0.95),AUC 0.88。
- 10和20分钟ETCO2以10 mm Hg为界值时阴性预测值超过0.95。
- 满足终止复苏严格标准需更低界值如5 mm Hg或联合其他预后指标,连续ETCO2监测可考虑作为TOR指南潜在辅助。
适用人群与场景
- 成人心脏骤停患者(纳入标准为原始研究报道ETCO2对ROSC预测的预后准确性)。
诊断标准与关键阈值
- 初始ETCO2最佳界值19.8 mm Hg(敏感度0.75,95%CI 0.60-0.85;特异度0.53,95%CI 0.40-0.65)。
- 10分钟ETCO2最佳界值15.7 mm Hg(敏感度0.91,95%CI 0.72-0.97;特异度0.68,95%CI 0.56-0.78)。
- 20分钟ETCO2最佳界值8.5 mm Hg(敏感度0.95,95%CI 0.53-0.99;特异度0.78,95%CI 0.39-0.95)。
处置流程与药物剂量
- 连续监测ETCO2可考虑作为当前终止复苏(TOR)指南的潜在辅助(作者认为)。
- 满足TOR严格标准需更低界值如5 mm Hg或联合其他预后指标(作者认为)。
研究设计与关键结果
- 系统评价与荟萃分析纳入14项研究共3186例成人心脏骤停患者。
- 初始ETCO2预测ROSC的AUC为0.67(95%CI 0.57-0.75)。
- 10分钟ETCO2预测ROSC的AUC为0.82(95%CI 0.61-0.91)。
- 20分钟ETCO2预测ROSC的AUC为0.88(95%CI 0.31-0.98)。
- 10和20分钟ETCO2以10 mm Hg为界值时阴性预测值超过0.95。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析。
- 局限:研究间存在显著异质性,需谨慎解读结果。
对床旁实践的改变
- 初始ETCO2预测ROSC准确性有限(AUC 0.67),不宜单独用于早期预后判断。
- 10和20分钟ETCO2以10 mm Hg为界值时阴性预测值超过0.95,可辅助识别ROSC可能性低的患者。
- 作者认为,连续ETCO2监测可考虑作为当前TOR指南的潜在辅助,但满足TOR严格标准需更低界值如5 mm Hg或联合其他预后指标。
- 研究间显著异质性要求对结果谨慎解读。
指南或共识出处
- PROSPERO注册号CRD42024527811。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cardiac arrest, a critical emergency with high fatality rates, needs accurate early predictors of resuscitation outcomes. End-tidal carbon dioxide (ETCO2) monitoring, reflecting tissue perfusion and metabolic activity, is highlighted in guidelines for predicting return of spontaneous circulation (ROSC). This systematic review and meta-analysis evaluates the prognostic accuracy of ETCO2 at various time points and cut-offs to enhance clinical decision-making during cardiac arrest.
METHODS: A systematic search of MEDLINE, Embase and the Cochrane Library identified relevant prognostic accuracy studies. Inclusion criteria were original articles reporting prognostic accuracy of ETCO2 for ROSC prediction in adult cardiac arrest patients. Sensitivity, specificity and 95% CIs were calculated for ETCO2 measurements at initial, 10 and 20 min using 2×2 contingency tables. A multiple thresholds model was used for meta-analysis, and the Median of Medians method analysed median ETCO2 values.
RESULTS: Fourteen studies with 3186 cardiac arrest patients were included. The optimal ETCO2cut-off was 19.8 mm Hg at initial (sensitivity 0.75 (95% CI 0.60 to 0.85), specificity 0.53 (95% CI 0.40 to 0.65)), 15.7 mm Hg at 10 min (sensitivity 0.91 (95% CI 0.72 to 0.97), specificity 0.68 (95% CI 0.56 to 0.78)) and 8.5 mm Hg at 20 min (sensitivity 0.95 (95% CI 0.53 to 0.99), specificity 0.78 (95% CI 0.39 to 0.95)). The highest area under the curve (AUC) was 0.88 (95% CI 0.31 to 0.98) at 20 min, followed by 0.82 (95% CI 0.61 to 0.91) at 10 min and 0.67 (95% CI 0.57 to 0.75) initially.
CONCLUSIONS: While initial ETCO2 demonstrates limited prognostic accuracy for ROSC with a pooled AUC of only 0.67, ETCO2 measurements taken at 10 and 20 min provide a negative predictive value exceeding 0.95 when using a cut-off of 10 mm Hg. However, to meet the stringent criteria for termination of resuscitation (TOR) decisions, a lower cut-off, such as 5 mm Hg, or the incorporation of additional prognostic indicators would be necessary. Serial ETCO2 monitoring could also be considered as a potential adjunct in current TOR guidelines. Significant variability between studies necessitates cautious interpretation of these results.
PROSPERO REGISTRATION NUMBER: CRD42024527811.
参考来源
- Lee YC, Lo YT, Chen CB, et al. Prognostic accuracy of end-tidal carbon dioxide in cardiac arrest: a systematic review and meta-analysis. Emerg Med J. 2026. PMID: 40987546. doi:10.1136/emermed-2025-214918
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。